Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 12/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL179222 | 0.91 | IDO1 (0.46) | IDO1SMN1; SMN2TSHRMEN1KMT2A | |
| SCHEMBL20198892 | 0.89 | IDO1 (0.49) | IDO1CYP3A4CYP2C9 | |
| SCHEMBL20198886 | 0.89 | IDO1 (0.50) | IDO1CYP3A4CYP2C9 | |
| SCHEMBL179217 | 0.89 | IDO1 (0.56) | IDO1CYP3A4CYP2C9 | |
| SCHEMBL20198906 | 0.86 | IDO1 (0.50) | IDO1SMN1; SMN2TSHRMEN1KMT2A | |
| SCHEMBL2757625 | 0.85 | IDO1 (0.52) | IDO1SMN1; SMN2TSHRMEN1KMT2A | |
| SCHEMBL20198887 | 0.84 | IDO1 (0.54) | IDO1SMN1; SMN2CYP3A4CYP2C9 | |
| SCHEMBL20199008 | 0.83 | IDO1 (0.52) | IDO1CYP3A4CYP2C9 | |
| SCHEMBL179218 | 0.83 | IDO1 (0.62) | IDO1CYP3A4CYP2C9 | |
| SCHEMBL20653655 | 0.81 | IDO1 (0.46) | IDO1SMN1; SMN2TSHRMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018095432-A1 | SULFOXIMINE, SULFONIMIDAMIDE, SULFONDIIMINE AND DIIMIDOSULFONAMIDE COMPOUNDS AS INHIBITORS OF INDOLEAMINE 2, 3-DIOXYGENASE | SHANGHAI FOCHON PHARMACEUTICAL CO., LTD. (CN) | 2018-05-31 | — | — | WO | disclosed |